Prevalence of CGG expansions of the FMR1 gene in a US population-based sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 5, 2012, Pages 589-597

  Seltzer, Marsha Mailick ^a   Baker, Mei Wang ^a   Hong, Jinkuk ^a   Maenner, Matthew ^a   Greenberg, Jan ^a   Mandel, Daniel ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

FMR1 premutation and gray zone CGG expansions; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIVORCE; ETHNIC DIFFERENCE; FEMALE; FMR1 GENE; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; FRAGILE X PRIMARY OVARIAN INSUFFICIENCY; FRAGILE X SYNDROME; GENE; GENE MUTATION; GENETIC DISORDER; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; TRINUCLEOTIDE REPEAT DISORDER; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; GENETICS, POPULATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PREVALENCE; TRINUCLEOTIDE REPEAT EXPANSION; UNITED STATES; WISCONSIN;

EID: 84861950670     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32065     Document Type: Article

References (44)

1. Bailey DB, Raspa M, Olmsted M, Holiday DB. 2008. Co-occurring conditions associated with FMR1 gene variations: Findings from a National Parent Survey. Am J Med Genet Part A 146A(16): 2060-2069.
2. Berkenstadt M, Ries-Levavi L, Cuckle H, Peleg L, Barkai G. 2007. Preconceptional and prenatal screening for fragile X syndrome: Experience with 40, 000 tests. Prenat Diagn 27(11): 991-994. DOI: 10.1002/pd.1815.
3. Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG. 2004. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Ann Neurol 57: 144-147.
4. Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman RJ. 2011. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Genet 72(2): 175-182.
5. Bretherick KL, Fluker MR, Robinson WP. 2005. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Human Genet 117(4): 376-382.
6. Chonchaiya W, Nguyen DB, Au J, Campos L, Berry-Kravis EM, Lohse K, et al. 2010. Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clin Genet 78: 38-46.
7. Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, et al. 2008. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet Part A 146A: 1009-1016.
8. Cornish KM, Hocking DR, Moss SA, Kogan CS. 2011. Selective executive markers of at-risk profiles associated with the fragile X premutation. Neurology 77(7): 618-622.
9. Crawford DC, Acuña JM, Sherman SL. 2001. FMR1 and the fragile X syndrome: Human genome epidemiology review. Genet Med 3(5): 359-371.
10. Cronister A, DiMaio M, Mahoney MJ, Donnenfeld AE, Hallam S. 2005. Fragile X syndrome carrier screening in the prenatal genetic counseling setting. Genet Med 7(4): 246-250. DOI: 10.1097/01.GIM.0000159898.90221.D3.
11. Cronister A, Teicher J, Rohlfs EM, Donnenfeld A, Hallam S. 2008. Prevalence and instability of fragile X alleles: Implications for offering fragile X prenatal diagnosis. Obstet Gynecol 111(3): 596.
12. Curlis Y, Zhang C, Holden JJA, Loesch PKKD, Mitchell RJ. 2005. Haplotype study of intermediate-length alleles at the fragile X (FMR1) gene: ATL1, FMRb, and microsatellite haplotypes differ from those found in common-size FMR1 alleles. Hum Biol 77(1): 137-151.
13. Dombrowski C, Levesque S, Morel M, Rouillard P, Morgan K, Rousseau F. 2002. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Human Mol Genet 11(4): 371.
14. Fernandez-Carvajal I, Walichiewicz P, Xiaosen X, Pan R, Hagerman PJ, Tassone F. 2009. Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn 11(4): 324-329.
15. Good PI. 2006. Resampling methods: A practical guide for data analysis. Boston: Birkhauser.
16. Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Tassone F, Harvey D, Rivera SM, Simon TJ. 2011. Adult female fragile X premutation carriers exhibit age- and CGG repeat length-related impairments on an attentionally-based enumeration task. Front Human Neurosci 5(63): 1-7.
17. Grigsby J, Brega AG, Jacquemont S, Loesch DZ, Leehey MA, Goodrich GK, Hagerman RJ, Epstein J, Wilson R, Cogswell JB, Jardini T, Tassone F, Hagerman PJ. 2006. Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J Neurol Sci 248: 227-233.
18. Hagerman PJ. 2008. The fragile X prevalence paradox. J Med Genet 45(8): 498-499.
19. Hagerman RJ, Hagerman PJ. 2002. The fragile X premutation: Into the phenotypic fold. Curr Opin Genet Dev 12(3): 278-283.
20. Hall DA, Berry-Kravis E, Zhang W, Tassone F, Spector E, Zerbe G, Hagerman PJ, Ouyang B, Leehey MA. 2011. FMR1 gray-zone alleles: Association with Parkinson's disease in women? Mov Disord 26(10): 1900-1906.
21. Hantash FM, Goos DG, Tsao D, Quan F, Buller-Burckle A, Peng M, Jarvis M, et al. 2010. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: Implications for fragile X syndrome carrier and newborn screening. Genet Med 12(3): 162-173. DOI: 10.1097/GIM.0b013e3181d0d40e.
22. Hauser RM, Sheridan J, Warren JR. 1998. Socioeconomic achievments of siblings in the life course: New findings from the Wisconsin Longitudinal Study (CDE Working Paper No. 98-02). University of Wisconsin-Madison, Center of Demography and Ecology.
23. Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL. 2008a. Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet 38(5): 493-502.
24. Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL. 2008b. No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50. Am J Human Genet 83(6): 692-702.
25. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, et al. 2004. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. J Am Med Assoc 291(4): 460-469.
26. Kogan CS, Turk J, Hagerman RJ, Cornish KM. 2008. Impact of the fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated tremor/ataxia syndrome: A controlled study. Am J Med Genet Part B 147B(6): 859-872.
27. Larsen LA, Grønskov K, Nørgaard-Pedersen B, Brøndum-Nielsen K, Hasholt L, Vuust J. 1997. High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis. Human Genet 100(5-6): 564-568.
28. Loesch DZ, Bui QM, Huggins RM, Mitchell RJ, Hgerman RJ, Tassone F. 2007. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J Med Genet 44: 200-204.
29. Lyon E, Laver T, Yu P, Jama M, Young K, Zoccoli M, Marlowe N. 2010. A simple, high-throughput assay for FRAGILE X expanded alleles using triple repeat primed PCR and capillary electrophoresis. J Mol Diagn 12(4): 505-511. Epub 2010 Apr 29.
30. Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, Hirsch B, Jacky P, McDowell GA, Popovich BB, Watson M, Wolff DJ. 2001. Technical standards and guidelines for fragile X: The first of a series of disease-specific supplements to the standards and guidelines for clinical genetics laboratories of the American College of Medical Genetics. Genet Med 3(3): 200-205.
31. Mitchell RJ, Holden JJA, Zhang C, Curlis Y, Slater HR, Burgess T, Kirkby KC, Carmichael A, Heading KD, Loesch DZ. 2005. FMR1 alleles in Tasmania: A screening study of the special educational needs population. Clin Genet 67(1): 38-46.
32. Otsuka S, Sakamoto Y, Siomi H, Itakura M, Yamamoto K, Matumoto H, Sasaki T, Kato N, Nanba E. 2010. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev 32(2): 110-114.
33. Peñagarikano O, Gil A, Télez M, Ortega B, Flores P, Veiga I, Peixoto A, Criado B, Arrieta I. 2004. A new insight into fragile X syndrome among Basque population. Am J Med Genet Part A 128A(3): 250-255.
34. Pirozzi F, Tabolacci E, Neri G. 2011. The FRAXopathies: Definition, overview, and update. Am J Med Genet Part A 155A(8): 1803-1816.
35. Radloff LS. 1977. The CES-D scale: A self report depression scale for research in the general population. Appl Psychol Meas 1(3): 385-401.
36. Rife M, Badenas C, Mallolas J, Jiménez L, Cervera R, Maya A, Glover G, et al. 2003. Incidence of fragile X in 5, 000 consecutive newborn males. Genet Test 7(4): 339-343.
37. Roberts JE, Bailey DB, Mankowski J, Ford A, Sideris J, Weisenfeld LA, Heath TM, Golden RN. 2009. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet Part B 150B(1): 130-139.
38. Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, Xuncla M, Badenas C, Kulisevsky J, et al. 2009. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Human Genet 17: 1359-1362.
39. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. 1995. Prevalence of carriers of premutation-size alleles of the FMRI gene-And implications for the population genetics of the fragile X syndrome. Am J Human Genet 57(5): 1006-1018.
40. Rylander-Rudqvist T, Håkansson N, Tybring G, Wolk A. 2006. Quality and quantity of saliva DNA obtained from the self-administrated oragene method-A pilot study on the cohort of Swedish men. Cancer Epidemiol Biomark Prev 15(9): 1742-1745.
41. Song FJ, Barton P, Sleightholme V, Yao GL, Fry-Smith A. 2003. Screening for fragile X syndrome: A literature review and modelling study. Health Technol Assess 7(16): 1-106.
42. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, et al. 2005. Association of FMR1 repeat size with ovarian dysfunction. Human Reprod 20: 402-412.
43. Toledano-Alhadef H, Basel-Vanagaite L, Magal N, Davidov B, Ehrlich S, Drasinover V, Taub E, Halpern GJ, Ginott N, Shohat M. 2001. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Human Genet 69(2): 351-360.
44. Tzeng CC, Tsai LP, Hwu WL, Lin SJ, Chao MC, Jong YJ, Chu SY, et al. 2005. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype. Am J Med Genet Part A 133A(1): 37-43.